Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Shareholder vote
confidence 95%
filed 2026-06-24
The 6-K discloses results of an extraordinary general meeting held on June 16, 2026, where shareholders voted on and approved four resolutions. The resolutions include a significant share reorganization (increase of authorized capital from 100 million to 50 billion shares, redesignation into Class A and Class B shares with differential voting rights), and adoption of amended memorandum and articles of association. This is a classic shareholder vote results disclosure under Item 5.07, and the share reorganization with dual-class voting structure is material to investors' assessment of voting control and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
The filing discloses results of an Extraordinary General Meeting held on June 24, 2026, where shareholders voted on seven proposals, including approval of a Business Combination Agreement with XDATA, a Reincorporation Merger, Nasdaq listing compliance, governance amendments, an incentive plan, and director appointments. All proposals passed with overwhelming support (3,205,004 votes for, 0 against on most proposals). This is a classic Item 5.07 shareholder vote results disclosure, and the underlying business combination is material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
The filing discloses results of Lucid Diagnostics' annual stockholder meeting held on June 24, 2026, including: (1) election of three Class B directors (Cox, Palumbo, Sparks) with detailed vote tallies; (2) approval of an amendment to increase authorized common shares from 300 million to 400 million shares; and (3) ratification of CBIZ CPAs P.C. as independent auditor. Item 5.07 explicitly governs shareholder vote results, and the 100-million-share authorization increase is material to investors assessing dilution risk and capital-raising capacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
Item 5.07
PAVmed held its annual meeting of stockholders on June 24, 2026, at which shareholders elected two Class A directors (Ronald M. Sparks and Timothy Baxter), approved amendments to the Employee Stock Purchase Plan increasing available shares from 15,774 to 215,774, and ratified CBIZ CPAs P.C. as the independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
CAVA Group disclosed final voting results from its June 22, 2026 annual meeting of stockholders, including election of two Class III directors (Brett Schulman and James D. White), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Iradimed's Annual Meeting of Stockholders held on June 23, 2026. The filing presents voting results for three proposals: (1) election of five directors (Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel, and James Hawkins), (2) ratification of RSM US LLP as independent auditor, and (3) advisory vote on named executive officer compensation. All three proposals passed with substantial majorities. This is a material governance event affecting investor understanding of board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder vote results from Foghorn's 2026 Annual Meeting of Stockholders held on June 24, 2026. The filing reports final voting tallies for four proposals: election of three Class III directors (Douglas Cole, Simba Gill, and B. Lynne Parshall), ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, and advisory approval of voting frequency on executive compensation. The detailed vote counts for each proposal are the core content of Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder vote results from LanzaTech's 2026 Annual Meeting held on June 23, 2026, covering three proposals: election of Class III directors (Dorri McWhorter and Jim Messina), ratification of BDO USA, P.C. as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed voting tallies for each proposal, which is the core content of Item 5.07 (Submission of Matters to a Vote of Security Holders).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
Item 5.07
Jushi Holdings held its 2026 Annual General and Special Meeting of Shareholders on June 24, 2026, with shareholders voting on four proposals: setting board size at five directors, electing five directors, ratifying auditors, and approving a special resolution to redomicile from British Columbia to Nevada. The redomiciliation vote is particularly material as it represents a significant corporate governance and jurisdictional change.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder voting results from C4 Therapeutics' Annual Meeting of Stockholders held on June 24, 2026, covering four proposals: election of Class III directors (Hirsch, Fawell, Koppikar), advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of an amendment to the 2020 Stock Option and Incentive Plan. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure, which is the hallmark of Item 5.07 shareholder vote results. This is material as it reflects stockholder approval of key governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder voting results from Wealthfront's 2026 Annual Meeting held on June 23, 2026. The filing reports final vote tallies for two proposals: election of Class I directors (David Fortunato and Andrew S. Rachleff) and ratification of Ernst & Young LLP as independent auditor. Both proposals passed with strong majorities, and the disclosure includes vote counts, broker non-votes, and abstentions as required under Item 5.07.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-24
The 6-K discloses the results of Nomad Foods' 2026 annual meeting of shareholders held on June 22, 2026, including voting outcomes for two proposals: (i) election of nine directors, with detailed vote tallies for each nominee, and (ii) ratification of PricewaterhouseCoopers LLP as independent auditor. This is a direct disclosure of shareholder vote results, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
GitLab held its Annual Meeting of Stockholders on June 17, 2026, with shareholders voting on three proposals: election of two Class II directors (Karen Blasing and Godfrey Sullivan), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
Serina Therapeutics held its 2026 Annual Meeting of Stockholders on June 17, 2026, with voting results disclosed covering eight proposals including director elections, authorization of additional common shares, equity plan amendment, preferred stock conversion, private placement securities exercise, say-on-pay votes, and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This 8-K Item 5.07 discloses the results of Candel Therapeutics' Annual Meeting of Stockholders held on June 23, 2026. The filing reports voting outcomes for two proposals: (i) election of four Class II directors (Edward J. Benz, Jr., M.D., Paul B. Manning, Maha Radhakrishnan, M.D., and Paul Peter Tak, M.D., Ph.D., FMedSci), all of whom were elected, and (ii) ratification of KPMG LLP as independent auditor, which was ratified. The detailed vote tallies for each director and the auditor ratification are provided, making this a clear shareholder vote results disclosure material to investors' understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder voting results from Axogen's 2026 annual meeting held on June 23, 2026. The filing reports final vote tabulations for three proposals: election of eight directors, ratification of Deloitte & Touche LLP as independent auditors, and an advisory vote on named executive officer compensation. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects shareholder approval of board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder voting results from Century Casinos' 2026 Annual Meeting of Stockholders held on June 22, 2026. The filing presents final vote tallies on three proposals: election of two Class II directors (Peter Hoetzinger and Mitchell Etess), ratification of Ernst & Young LLP as independent auditor, and an advisory vote on named executive officer compensation. This is the quintessential Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Dollar Tree held its 2026 Annual Meeting of Shareholders on June 16, 2026, with voting results on four matters: election of ten directors, advisory approval of named executive officer compensation, ratification of KPMG LLP as independent auditor, and a shareholder proposal on written consent rights.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-23
EX-99.1
The exhibit discloses voting results from Metalla's annual general meeting held June 23, 2026, including detailed vote tallies for seven director nominees (all approved with >95% support), approval of KPMG LLP as auditor, and approval of the share compensation plan. This is a classic shareholder_vote_results disclosure. The concurrent announcement of Sandeep Singh's market purchase of 150,000 shares and matching RSU award is secondary context to his election as director and is not a separate material event requiring distinct classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder vote results from the June 17, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes for three proposals: election of a Class II director (Matthew C. Winger), ratification of the independent auditor (Stephano Slack LLC), and advisory approval of named executive officer compensation. All three proposals were approved. This is a standard Item 5.07 disclosure of shareholder meeting results, which is material to investors as it reflects governance decisions and shareholder approval of key matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure presents the final voting results from Novavax's June 18, 2026 Annual Meeting of Stockholders, including election of three Class I directors, advisory approval of named executive officer compensation, amendments to two equity incentive plans, and ratification of Ernst & Young LLP as independent auditor. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms governance outcomes and shareholder approval of key compensation and equity plan matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder vote results from AudioEye's 2026 Annual Meeting of Stockholders held on June 22, 2026. The filing presents the final voting tallies for two proposals: election of five directors and advisory approval of named executive officer compensation. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects stockholder approval of governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-23
Item 8.01
The filing discloses results of a shareholder vote held on June 17, 2026, regarding an extension of TDAC's deadline to consummate a business combination. The press release reports that 95% of shares voted were in favor of the extension and that 85% of shareholders did not redeem their shares, with $156.8mm remaining in trust. This is a direct disclosure of shareholder vote results under Item 5.07, material to investors assessing the likelihood and funding status of the proposed ProLogium merger.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 filing discloses the results of Fortress Biotech's June 17, 2026 annual meeting of stockholders, including voting outcomes for two proposals: (i) election of seven directors and (ii) ratification of KPMG LLP as independent auditor. The detailed vote tallies for each director and the auditor ratification constitute a classic shareholder_vote_results disclosure, which is material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Orchestra BioMed's 2026 Annual Meeting of Stockholders held on June 23, 2026. The filing presents voting results for five proposals: election of three Class III directors (David P. Hochman, Darren R. Sherman, and Eric S. Fain), ratification of Ernst & Young LLP as independent auditor, approval of the 2026 Employee Stock Purchase Plan, advisory vote on named executive officer compensation, and advisory vote on compensation vote frequency. All proposals passed. This is a material governance event affecting investor understanding of board composition and corporate governance decisions.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-23
EX-99.1
This exhibit is a formal Report of Voting Results filed pursuant to Section 11.3 of National Instrument 51-102, disclosing the outcomes of Eldorado Gold's Annual Shareholders Meeting held on June 23, 2026. It reports ballot results for election of nine directors, appointment of KPMG LLP as auditors, authorization of auditor remuneration, and an advisory vote on executive compensation — all standard shareholder-vote matters that materially affect governance and investor confidence in the company's leadership and oversight.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-23
EX-99.1
This news release announces the results of Eldorado Gold's 2026 Annual Meeting of Shareholders held on June 23, 2026. It discloses the election of nine directors with specific voting tallies (votes for/against each nominee), shareholder approval of independent auditors, authorization of auditor compensation, and approval of an advisory resolution on executive compensation. The disclosure of director elections and shareholder votes at an annual meeting directly matches the `shareholder_vote_results` taxonomy category, and the results are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
Broadway Financial Corporation held its Annual Meeting of Stockholders on June 17, 2026, with voting results on four matters: election of three directors (Brian E. Argrett, Mary Ann Donovan, Mary M. Hentges) to serve until 2029; ratification of Crowe LLP as independent auditor for fiscal 2026; advisory approval of executive compensation; and stockholder selection of annual frequency for future advisory compensation votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder voting results from EverCommerce's June 18, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports the voting outcomes for two proposals: election of three Class II Directors (Amy Guggenheim Shenkan, John Rudella, and Mark Hastings) and ratification of Ernst & Young LLP as independent auditor. All three director nominees and the auditor ratification passed with overwhelming majorities, representing a routine but material governance event that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure presents the complete voting results from Genco's June 18, 2026 Annual Meeting of Shareholders, including election of six directors, advisory vote on executive compensation, approval of equity plan amendment, ratification of auditors, ratification of shareholder rights agreement, and rejection of two shareholder proposals. The detailed tabulation of votes for and against each proposal is the hallmark of shareholder_vote_results classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-23
Item 5.07
Green Dot shareholders voted on June 23, 2026 to approve four proposals: adoption of the Merger Agreement with CommerceOne and Smith Ventures (99.6% in favor), approval of the Separation Agreement (99.6% in favor), advisory approval of transaction-related executive compensation (87.7% in favor), and adjournment authority (98.8% in favor). All proposals were approved by the requisite vote, representing a critical milestone in a transformative transaction involving the acquisition of Green Dot Bank by CommerceOne and the separation of Green Dot's fintech operations to Smith Ventures.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-06-23
EX-99.1
The exhibit is a press release announcing results of Skeena's Annual General Meeting held June 22, 2026, disclosing shareholder approval of director reelection, the Rolling Omnibus Incentive Plan, auditor reappointment, and board size. The detailed voting table shows voting percentages for each director nominee. While the exhibit also includes management changes (appointment of Ryan Maloney as VP Corporate Development and transition of Justin Himmelright to Strategic Advisor), the primary disclosed event is the AGM vote results, which is material to investors as it confirms board composition and governance approvals. The management changes are secondary announcements within the same release.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Anika Therapeutics held its Annual Meeting on June 18, 2026, with stockholders voting on five proposals: election of three Class III directors (Fischetti, Henneman, Griffin), ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, approval of the Revised Seventh Amended Plan increasing equity reserves, and amendment of the ESPP increasing share reserves. The filing reports the final voting results for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
PRA Group held its 2026 Annual Meeting of Stockholders on June 16, 2026, with voting results on four matters: election of nine directors, ratification of Ernst & Young LLP as independent auditor, advisory vote on named executive officer compensation, and amendment to the 2022 Omnibus Incentive Plan increasing share authorization by 3,500,000 shares.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder voting results from an annual and special meeting held on June 22, 2026. The filing reports the outcomes of three proposals: fixing the board size at seven directors, electing seven director nominees, and appointing PricewaterhouseCoopers LLP as independent auditor. All proposals were approved with detailed vote tallies provided for each matter, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 discloses the results of MiNK Therapeutics' Annual Meeting of Stockholders held on June 17, 2026, including the election of three Class II Directors (Garo Armen, Barbara Ryan, and John Holcomb) and ratification of KPMG LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Agenus Inc.'s Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting outcomes for six proposals: election of Class II Directors (Garo Armen and Jennifer Buell), approval of amendments to equity plans, a stock option exchange program, advisory compensation vote, and auditor ratification. All proposals were approved by stockholders, with detailed vote tallies provided for each matter. This is a material governance event affecting investor understanding of board composition and equity incentive structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 19, 2026. The filing reports voting outcomes for two proposals: (1) election of eleven directors with detailed vote tallies for each nominee, and (2) advisory approval of named executive officer compensation. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects governance decisions and shareholder sentiment on board composition and executive compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
First Eagle Private Credit Fund held its 2026 Annual Meeting of Shareholders on June 17, 2026, with shareholders voting to elect two Class I trustees (Nancy Hawthorne and Patrick Coyne, each receiving 12,403,652 votes for with zero withheld) and ratify PricewaterhouseCoopers LLP as independent auditor (12,403,652 votes for, zero against, zero abstained).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of LeonaBio's 2026 Annual Meeting of Stockholders held on June 22, 2026. The filing presents final voting tallies for four proposals: election of three Class III directors (Kelly A. Romano, James A. Johnson, and Natalie Holles), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on the frequency of future say-on-pay votes (determined to be every 3 years). The disclosure includes vote counts, broker non-votes, and the Board's determination based on the results, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
IDEAYA held its 2026 Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on three proposals: election of three Class I directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The filing reports the tabulated vote counts for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Olema's June 17, 2026 annual meeting of stockholders. The filing presents final voting tallies for three proposals: election of four Class III directors (all elected), advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. The disclosure directly matches the shareholder_vote_results event type and is material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 filing discloses the results of Apollo Debt Solutions BDC's Annual Meeting of Shareholders held on June 18, 2026, including voting outcomes for two proposals: election of two Class II Trustees and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (FOR, WITHHELD, AGAINST, ABSTAIN, BROKER-NON-VOTE) are the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure reports the results of MidCap Financial Investment Corporation's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for two proposals: election of two Class I Directors (Pearlman and Powell) and ratification of Deloitte & Touche LLP as independent auditor. The tabulated vote counts for each proposal are the core content of the filing, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on four proposals: election of three directors (Tracey Benford, David M. McCoy, and Robert B. Stewart, Jr.), advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and ratification of KPMG LLP as independent auditor. The filing presents vote tallies (For, Against, Withheld, Abstained, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-23
Item 5.07
On June 23, 2026, Willis Lease Finance Corp stockholders approved a three-for-one forward stock split (Proposal 2) at a reconvened Annual Meeting, with 6,151,386 votes in favor, 1,187,377 against, and 6,752 abstentions. The filing also confirms approval of all five 2026 proxy proposals with overwhelming shareholder support.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
FibroBiologics held its Annual Meeting on June 22, 2026, with stockholders voting on four proposals: election of Class III director Pete O'Heeron, ratification of WithumSmith+Brown, PC as independent auditor, approval of warrant issuance under Nasdaq Rule 5635(d), and approval of the 2026 Equity and Incentive Compensation Plan. All proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of United Parks & Resorts' 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents detailed voting tallies for four proposals: election of ten directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on say-on-pay frequency. All proposals passed with substantial majorities, making this a routine but material shareholder governance event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-23
The 6-K discloses results of an extraordinary general meeting of shareholders held on June 18, 2026, with voting tallies for four distinct proposals: (1) approval of a massive increase in authorized share capital from US$20 million to US$10 billion, (2) adoption of amended memorandum of association reflecting the capital increase, (3) approval of share consolidation at a ratio between 2:1 and 250:1 at board discretion, and (4) adoption of amended memorandum and articles reflecting the consolidation. All four proposals passed with substantial majorities. These are material structural changes to the company's capitalization and governance requiring shareholder approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Shareholders voted at the June 16, 2026 annual meeting on three proposals: setting board size at six directors, electing six director nominees (Michael McFadden, Kenneth Cawkell, Rajeev Bakshi, Phillip Mertz, Robert Wills, and Bethany Sensenig), and ratifying CBIZ CPAs P.C. as the independent auditor. All three proposals passed.
View raw filing on EDGAR →